Burden of communicable diseases and cost of illness: Asia pacific region

References

• Tran BX, Nong VM, Maher RM, et al. A systematic review of scope and quality of health economic evaluation studies in Vietnam. PLoS One. 2014;9(8):e103825.
   PubMed Web of Science ®Google Scholar
• Shah S, Abbas G, Hanif M, et al. Increased burden of disease and role of health economics: Asia-pacific region. Expert Rev Pharmacoecon Outcomes Res. 2019;19(5): 517–528.
   PubMed Web of Science ®Google Scholar
• Doherty J, Kamae I, Lee KK, et al. What is next for pharmacoeconomics and outcomes research in Asia? Value Health. 2004;7(2):118–132.
   PubMed Web of Science ®Google Scholar
• Poudel AN, Newlands D, Simkhada P. Economic burden of HIV/AIDS upon households in Nepal: a critical review. Nepal J Epidemiol. 2015;5(3):502.
   PubMed Web of Science ®Google Scholar
• Organization WH. Report on AIDS. Geneva, Switzerland: World Health Organization; 2004.
   Google Scholar
• amfAR TFfAR. Statistics: worldwide. 2019 [cited 2019 Aug]. Available from: https://www.amfar.org/worldwide-aids-stats/
   Google Scholar
• amfAR TFfAR. HIV in Asia. 2019.
   Google Scholar
• Cucunawangsih LNPH. Trends of dengue disease epidemiology. Virology. 2017;8:1178122X17695836.
   PubMedGoogle Scholar
• Organization WH. WHO report on control and prevention of dengue, 2019. 2019.
   Google Scholar
• Roth A, Mercier A, Lepers C, et al. Concurrent outbreaks of dengue, chikungunya and Zika virus infections – an unprecedented epidemic wave of mosquito-borne viruses in the Pacific 2012–2014. Eurosurveillance. 2014;19(41):20929.
   Web of Science ®Google Scholar
• Musso D, Gubler DJ. Zika virus: following the path of dengue and chikungunya? Lancet. 2015;386(9990):243–244.
   PubMed Web of Science ®Google Scholar
• Tiga DC, Undurraga EA, Ramos-Castañeda J, et al. Persistent symptoms of dengue: estimates of the incremental disease and economic burden in Mexico. Am J Trop Med Hyg. 2016;94(5):1085–1089.
   PubMed Web of Science ®Google Scholar
• Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continuing global threat. Nature Rev Microbiol. 2010;8(12supp):S7.
   PubMedGoogle Scholar
• Suaya JA, Shepard DS, Siqueira JB, et al. Cost of dengue cases in eight countries in the Americas and Asia: a prospective study. Am J Trop Med Hyg. 2009;80(5):846–855.
   PubMed Web of Science ®Google Scholar
• Lam SK, Burke D, Capeding MR, et al. Preparing for introduction of a dengue vaccine: recommendations from the 1st dengue v2V Asia-Pacific meeting. Vaccine. 2011;29(51):9417–9422.
   PubMed Web of Science ®Google Scholar
• Rio SSS. Dengue-guidelines for diagnosis, treatment, prevention and control. 2009.
   Google Scholar
• Rao TR. Immunological surveys of arbovirus infections in South-East Asia, with special reference to dengue, chikungunya, and Kyasanur forest disease. Bull World Health Organ. 1971;44(5):585.
   PubMed Web of Science ®Google Scholar
• Shepard DS, Undurraga EA, Halasa YA. Economic and disease burden of dengue in Southeast Asia. PLoS Negl Trop Dis. 2013;7(2):e2055.
   PubMed Web of Science ®Google Scholar
• Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504.
   PubMed Web of Science ®Google Scholar
• Murray NEA, Quam MB, Wilder-Smith A. Epidemiology of dengue: past, present and future prospects. Clin Epidemiol. 2013;5:299.
   PubMedGoogle Scholar
• Rodríguez RC, Carrasquilla G, Porras A, et al. The burden of dengue and the financial cost to Colombia, 2010–2012. Am J Trop Med Hyg. 2016;94(5):1065–1072.
   PubMed Web of Science ®Google Scholar
• Beauté J, Vong S. Cost and disease burden of dengue in Cambodia. BMC Public Health. 2010;10(1):521.
   PubMedGoogle Scholar
• Shepard DS, Halasa YA, Tyagi BK, et al. Economic and disease burden of dengue illness in India. Am J Trop Med Hyg. 2014;91(6):1235–1242.
   PubMed Web of Science ®Google Scholar
• Arkin F. Dengue researcher faces charges in vaccine fiasco. Washington, DC: American Association for the Advancement of Science; 2019.
   Google Scholar
• Ren M. Greater political commitment needed to eliminate malaria. Infect Dis Poverty. 2019;8(1):28.
   PubMedGoogle Scholar
• Maude RJ, Mercado CEG, Rowley J, et al. Estimating malaria disease burden in the Asia-Pacific. Wellcome Open Res. 2019;4:1–20.
   Google Scholar
• Silal SP, Shretta R, Celhay OJ, et al. Malaria elimination transmission and costing in the Asia-Pacific: a multi-species dynamic transmission model. Wellcome Open Res. 2019;4:1–30.
   Google Scholar
• Wangdi K, Clements AC. Ending malaria transmission in the Asia Pacific Malaria Elimination Network (APMEN) countries: challenges and the way forward. In: Manguin S, editor. Towards malaria elimination: a leap forward. London, UK: Intech Open; 2018. p. 201.
   Google Scholar
• Averting H. (AIDS AVERT). HIV and AIDS in Asia & The Pacific regional overview. 2017 [cited 2020 Feb 20]. p. 6. Available from: https://wwwavert org/professionals/hiv-around-world/asia-pacific/overview
   Google Scholar
• Reeves JD, Doms RW. Human immunodeficiency virus type 2. J Gen Virol. 2002;83(6):1253–1265.
   PubMedGoogle Scholar
• Viravaidya M, Obremskey A, Myers C. The economic impact of AIDS on Thailand [MA Thesis on the Economic Impact of AIDS]. Thailand (Harvard): Harvard Institute for International Development, (draft); 1996. cited in Myers C.
   Google Scholar
• Ruxrungtham K, Brown T, Phanuphak P. HIV/AiDS in Asia. Lancet. 2004;364(9428):69–82.
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Naemura M. Epidemiological characteristics on human immunodeficiency virus infection and acquired immunodeficiency syndrome in Japan. Int J STD AIDS. 1994;5(4):273–278.
   PubMed Web of Science ®Google Scholar
• Chiang S-R, Chuang Y-C. Vibrio vulnificus infection: clinical manifestations, pathogenesis, and antimicrobial therapy. J Microbiol Immunol Infect. 2003;36(2):81–88.
   PubMedGoogle Scholar
• Weniger B, Limpakarnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS. 1991;5(Suppl. 2):S71–S85.
   PubMedGoogle Scholar
• Newmann S, Sarin P, Kumarasamy N, et al. Marriage, monogamy and HIV: a profile of HIV-infected women in South India. Int J STD AIDS. 2000;11(4):250–253.
   PubMed Web of Science ®Google Scholar
• Xu F, Kilmarx PH, Supawitkul S, et al. HIV-1 seroprevalence, risk factors, and preventive behaviors among women in northern Thailand. J Acquir Immune Defic Syndr. 2000;25(4):353–359.
   PubMed Web of Science ®Google Scholar
• Bates I, Fenton C, Gruber J, et al. Vulnerability to malaria, tuberculosis, and HIV/AIDS infection and disease. Part II: determinants operating at environmental and institutional level. Lancet Infect Dis. 2004;4(6):368–375.
   PubMed Web of Science ®Google Scholar
• Pitayanon S, Kongsin S, Janjareon W. The economic impact of HIV/AIDS mortality on households in Thailand. In: Giles C, editor. The economics of HIV and AIDS: the case of South and South East Asia. US: CiteSeerX; 1997. p. 1–34.
   Google Scholar
• Foundation THJKF. The global HIV/AIDS epidemic. 2019 Sep 9 [cited 2019 Sep]. Available from: https://www.kff.org/global-health-policy/fact-sheet/the-global-hivaids-epidemic/
   Google Scholar
• Lua PL, Mustapha N, Abdullah R, et al. The experiences and challenges in caring for HIV/AIDS patients: a qualitative exploration among Muslim family caregivers in Terengganu, Malaysia. ASEAN J Psychiatry. 2014;15(2):120–130.
   Google Scholar
• Duraisamy P, Ganesh A, Homan R, et al. Costs and financial burden of care and support services to PLHA and households in South India. AIDS Care. 2006;18(2):121–127.
   PubMed Web of Science ®Google Scholar
• Mahal A, Rao B. HIV/AIDS epidemic in India: an economic perspective. Indian J Med Res. 2005;121(4):582–600.
   PubMed Web of Science ®Google Scholar
• Kumarasamy N, Venkatesh K, Mayer K, et al. Financial burden of health services for people with HIV/AIDS in India. Indian J Med Res. 2007;126(6):509.
   PubMed Web of Science ®Google Scholar
• Bhavsarl AB, Srivastava D. Economic burden of HIV/AIDS on households: cross-sectional study in the context of Navi Mumbai, India. Global J Med Public Health. 2015;4(6):1–11.
   Google Scholar
• Poudel AN, Newlands D, Simkhada P. The economic burden of HIV/AIDS on individuals and households in Nepal: a quantitative study. BMC Health Serv Res. 2017;17(1):76.
   PubMedGoogle Scholar
• Puri M, Horstman R, Matthews Z, et al. Examining out-of-pocket expenditures on reproductive and sexual health among the urban population of Nepal. Popul Rev. 2008;47:2.
   Google Scholar
• Thapa N. Receiving cost of antiretroviral therapy (ART) service and impact of ART service on health status, income and productivity of people living with human immunodeficiency virus/acquired immunodeficiency syndrome in Nepal [Master Thesis]. Kathmandu: Tribhuvan University, Maharajgunj; 2007.
   Google Scholar
• Pradhan P, Bhatta G, Bam K. Cost-effectiveness of models of care quality for children affected by HIV and AIDS in Nepal. Health Prospect. 2012;11:19–25.
   Google Scholar
• Ghailan K, Jusoh A, Rizal M, et al. Impact of HIV/AIDS morbidity on households economy in Malaysia. Global J Health Sci. 2010;2(2):142.
   Google Scholar
• Knodel J, Im-Em W. The economic consequences for parents of losing an adult child to AIDS: evidence from Thailand. Soc Sci Med. 2004;59(5):987–1001.
   PubMed Web of Science ®Google Scholar
• Over M. HIV/AIDS treatment and prevention in India: modeling the costs and consequences. Washington, DC: The World Bank; 2004.
   Google Scholar
• Liu GG, Guo JJ, Smith SR. Economic costs to business of the HIV/AIDS epidemic. Pharmacoeconomics. 2004;22(18):1181–1194.
   PubMed Web of Science ®Google Scholar
• Packierisamy PR, Ng C-W, Dahlui M, et al. Cost of dengue vector control activities in Malaysia. Am J Trop Med Hyg. 2015;93(5):1020–1027.
   PubMed Web of Science ®Google Scholar
• Garg A, Garg J, Rao Y, et al. Prevalence of dengue among clinically suspected febrile episodes at a teaching hospital in North India. J Infect Dis Immun. 2011;3(5):85–89.
   Google Scholar
• Hsu JC, Hsieh C-L, Lu CY. Trend and geographic analysis of the prevalence of dengue in Taiwan, 2010–2015. Inter J Infect Dis. 2017;54:43–49.
   PubMed Web of Science ®Google Scholar
• Bhatt S, Gething P, Brady O, et al. Dengue: prevention and control. 2013.
   Google Scholar
• Brady OJ, Gething PW, Bhatt S, et al. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis. 2012;6(8):e1760.
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. An observation on correlation between rainfall and the prevalence of clinical cases of dengue in Thailand. J Vector Borne Dis. 2006;43(2):73.
   PubMedGoogle Scholar
• Suetens C, Hopkins S, Kolman J, et al.; European Centre for Disease Prevention and Control (ECDC). Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. 2011.
   Google Scholar
• Guzman MG, Harris E. Dengue. Lancet. 2015;385(9966):453–465.
   PubMed Web of Science ®Google Scholar
• Suaya JA, Shepard DS, Beatty ME. Dengue: burden of disease and costs of illness. TDr/SWg/08. Geneva: World health organization on behalf of the Special Programme for research and Training in Tropical Diseases; 2007.
   Google Scholar
• Libraty DH, Young PR, Pickering D, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186(8):1165–1168.
   PubMed Web of Science ®Google Scholar
• Messina JP, Brady OJ, Scott TW, et al. Global spread of dengue virus types: mapping the 70 year history. Trends Microbiol. 2014;22(3):138–146.
   PubMed Web of Science ®Google Scholar
• Carrasco LR, Lee LK, Lee VJ, et al. Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore. PLoS Negl Trop Dis. 2011;5(12):e1426.
   PubMed Web of Science ®Google Scholar
• Stanaway JD, Shepard DS, Undurraga EA, et al. The global burden of dengue: an analysis from the global burden of disease study 2013. Lancet Infect Dis. 2016;16(6):712–723.
   PubMed Web of Science ®Google Scholar
• Anderson KB, Chunsuttiwat S, Nisalak A, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet. 2007;369(9571):1452–1459.
   PubMed Web of Science ®Google Scholar
• O’Reilly KM, Hendrickx E, Kharisma DD, et al. Estimating the burden of dengue and the impact of release of wMel Wolbachia-infected mosquitoes in Indonesia: a modelling study. BMC Med. 2019;17(1):1–14.
   PubMed Web of Science ®Google Scholar
• Clark DV, Mammen MP Jr, Nisalak A, et al. Economic impact of dengue fever/dengue hemorrhagic fever in Thailand at the family and population levels. Am J Trop Med Hyg. 2005;72(6):786–791.
   PubMed Web of Science ®Google Scholar
• Stahl H-C, Butenschoen VM, Tran HT, et al. Cost of dengue outbreaks: literature review and country case studies. BMC Public Health. 2013;13(1):1048.
   PubMedGoogle Scholar
• Huy R, Wichmann O, Beatty M, et al. Cost of dengue and other febrile illnesses to households in rural Cambodia: a prospective community-based case-control study. BMC Public Health. 2009;9(1):155.
   PubMedGoogle Scholar
• Edillo FE, Halasa YA, Largo FM, et al. Economic cost and burden of dengue in the Philippines. Am J Trop Med Hyg. 2015;92(2):360–366.
   PubMed Web of Science ®Google Scholar
• Shepard DS, Suaya JA, Halstead SB, et al. Cost-effectiveness of a pediatric dengue vaccine. Vaccine. 2004;22(9–10):1275–1280.
   PubMed Web of Science ®Google Scholar
• Garg P, Nagpal J, Khairnar P, et al. Economic burden of dengue infections in India. Trans R Soc Trop Med Hyg. 2008;102(6):570–577.
   PubMed Web of Science ®Google Scholar
• Kongsin S, Jiamton S, Suaya JA, et al. Cost of dengue in Thailand. 2010.
   Google Scholar
• Luong Q, Coudeville L, Pollisard L, et al. Assessing the economic burden of dengue in Southern Viet Nam: results of a prospective multicenter cost study. Ho Chi Minh (Viet Nam): Pasteur Institute; 2012. p. 28.
   Google Scholar
• Qureshi AW, Khan Z-U, Khan L, et al. Prevalence of malaria, typhoid and co-infection in district DIR (lower), Pakistan. Biosci J. 2019;35:1.
   Web of Science ®Google Scholar
• Guerin PJ, Olliaro P, Nosten F, et al. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. Lancet Infect Dis. 2002;2(9):564–573.
   PubMed Web of Science ®Google Scholar
• Sanofi. Fighting malaria. 2019 Apr [cited 2019 Apr]. Available from: http:/www.sanofi.com/-/media/Project/One-Sanofi-Web/Websites/Global/Sanofi-COM/Home/common/docs/our-responsibility/documents-center/Fighting-Malaria.pdf?Ia=en
   Google Scholar
• Islamabad DoMCD. Pakistan malaria annual report 2019. 2019.
   Google Scholar
• Shretta R, Avanceña AL, Hatefi A. The economics of malaria control and elimination: a systematic review. Malar J. 2016;15(1):593.
   PubMedGoogle Scholar
• Mayor S. WHO report shows progress in efforts to reduce malaria incidence. London, UK: British Medical Journal Publishing Group; 2008.
   Google Scholar
• Nghiem LT, Soliman T, Yeo DC, et al. Economic and environmental impacts of harmful non-indigenous species in Southeast Asia. PLoS One. 2013;8(8):e71255.
   PubMed Web of Science ®Google Scholar
• Kumar A, Valecha N, Jain T, et al. Burden of malaria in India: retrospective and prospective view. Am J Trop Med Hyg. 2007;77(6_Suppl):69–78.
   PubMed Web of Science ®Google Scholar
• Schmidt S. Malaria: the “unwanted souvenir”. South Afr Pharm Assistant. 2019;19(4):8–13.
   Google Scholar
• Gupta I, Chowdhury S. Economic burden of malaria in India: the need for effective spending. WHO South East Asia J Public Health. 2014;3(1):95.
   PubMedGoogle Scholar
• Haque U, Overgaard HJ, Clements AC, et al. Malaria burden and control in Bangladesh and prospects for elimination: an epidemiological and economic assessment. Lancet Glob Health. 2014;2(2):e98–e105.
   PubMed Web of Science ®Google Scholar
• Kyaw SS, Drake T, Ruangveerayuth R, et al. Cost of treating inpatient falciparum malaria on the Thai-Myanmar border. Malar J. 2014;13(1):416.
   PubMedGoogle Scholar
• India To. Malaria costs India Rs 11,640 crore yearly, dengue Rs 6,000 crore: WHO February 6, 2016 [cited 2016 Feb 18]. Available from: www.timesofindia.com/india/malaria-cost-india
   Google Scholar
• Karyana M, Devine A, Kenangalem E, et al. Treatment-seeking behaviour and associated costs for malaria in Papua, Indonesia. Malar J. 2016;15(1):536.
   PubMedGoogle Scholar